December 4th 2024
EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.